Donor Statin Treatment for Prevention of Severe Acute GVHD After Nonmyeloablative Hematopoietic Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Atorvastatin (Primary) ; Ciclosporin; Fludarabine; Mycophenolate mofetil
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 13 Jan 2017 Planned primary completion date changed from 1 Jun 2017 to 1 May 2018.
- 24 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.